Scientists test new weight loss Shot's impact on everyday drugs
NCT ID NCT06564441
Summary
This study aimed to understand if a new weekly injection for weight management (BI 456906) changes how the body processes three common substances: caffeine, a sleep aid (midazolam), and an antidepressant (bupropion). It involved 34 otherwise healthy adults with overweight or obesity. Researchers compared blood levels of these substances taken alone to levels taken while also receiving the weight loss injection over a 13-month period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Life Science Services - Clinical Research
Edegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.